
Senior Scientist, Analytical Separations R&D
Merck
Summary
Analytical Enabling Capabilities is seeking a Senior Scientist to join our Vaccine Discovery Analytical Research team located in West Point, PA. In this role, an individual will work with a team of scientists to conduct state-of-the-art analytical techniques, including separations (such as HPLC, UPLC, AF4, electrophoresis, and CE), spectroscopic techniques (NMR, MS, UV-VIS, IR, MALS, and Fluorescence), and classical wet chemistry techniques.
Job description
The individual should also have in-depth separations knowledge to facilitate vaccine characterization and quality control for a number of vaccine platforms, such as protein, subunit and live virus vaccines.
Responsibilities
- Lead assay development and drive scientific contributions at program levels
- Engage with product teams to characterize vaccines supporting process development, formulation development, vaccine characterization, and method and transfers
- Provide technical guidance to other scientists
- Evaluate new technologies and drive innovations to influence trends in industry
- Prioritize and work in a collaborative manner in a fast-paced, integrated, multidisciplinary team environment
Education Minimum Requirement
PhD or a Master's degree with 4+ years industry, OR a Bachelor's degree with 6+ year experience in Chemistry, Chemical Engineering, Biomedical Engineering, Biochemistry, Structural Biology or a closely related field.
Required Experience and Skills
- In-depth knowledge and understanding of chemistry and separations (UPLC, HPLC, CE, and electrophoresis)
- Experience with protein characterization and protein interactions (Electrophoresis, SPR, ITC, MALS)
- Ability to troubleshoot technical issues related to separation methodology
- Independent analytical problem-solving capabilities
- Strong verbal & written communication skills
- Capable of multi-tasking and managing multiple projects
- Motivated to learn new skills, willingness to take on new challenges, and scientific curiosity
Preferred Experience and Skills
- Experience working on vaccine research and/or development
- Experience with assay robustness evaluation
- Solid computer skills and ability to script analytical analysis workbooks
- Experienced with automated laboratory instrumentation
- Experience with biophysical methodologies
Requirements
- PhD or a Master's degree with 4+ years industry, OR a Bachelor's degree with 6+ year experience in Chemistry, Chemical Engineering, Biomedical Engineering, Biochemistry, Structural Biology or a closely related field
- In-depth knowledge and understanding of chemistry and separations (UPLC, HPLC, CE, and electrophoresis)
- Experience with protein characterization and protein interactions (Electrophoresis, SPR, ITC, MALS)
- Ability to troubleshoot technical issues related to separation methodology
- Independent analytical problem-solving capabilities
- Strong verbal & written communication skills
- Capable of multi-tasking and managing multiple projects
- Motivated to learn new skills, willingness to take on new challenges, and scientific curiosity
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.